182 related articles for article (PubMed ID: 30928063)
1. A Monte Carlo study on the feasibility of real-time in vivo source tracking during ultrasound based HDR prostate brachytherapy treatments.
Poder J; Cutajar D; Guatelli S; Petasecca M; Howie A; Bucci J; Carrara M; Rosenfeld A
Phys Med; 2019 Mar; 59():30-36. PubMed ID: 30928063
[TBL] [Abstract][Full Text] [Related]
2. HDR brachytherapy in vivo source position verification using a 2D diode array: A Monte Carlo study.
Poder J; Cutajar D; Guatelli S; Petasecca M; Howie A; Bucci J; Rosenfeld A
J Appl Clin Med Phys; 2018 Jul; 19(4):163-172. PubMed ID: 29855128
[TBL] [Abstract][Full Text] [Related]
3. BrachyView, a novel inbody imaging system for HDR prostate brachytherapy: design and Monte Carlo feasibility study.
Safavi-Naeini M; Han Z; Cutajar D; Guatelli S; Petasecca M; Lerch ML; Franklin DR; Jakubek J; Pospisil S; Bucci J; Zaider M; Rosenfeld AB
Med Phys; 2013 Jul; 40(7):071715. PubMed ID: 23822419
[TBL] [Abstract][Full Text] [Related]
4. The feasibility study and characterization of a two-dimensional diode array in "magic phantom" for high dose rate brachytherapy quality assurance.
Espinoza A; Beeksma B; Petasecca M; Fuduli I; Porumb C; Cutajar D; Corde S; Jackson M; Lerch ML; Rosenfeld AB
Med Phys; 2013 Nov; 40(11):111702. PubMed ID: 24320410
[TBL] [Abstract][Full Text] [Related]
5. BrachyView: initial preclinical results for a real-time in-body HDR PBT source tracking system with simultaneous TRUS image fusion.
Alnaghy S; Cutajar DL; Safavi-Naeini M; George S; Howie A; Bece A; Bucci JA; Jakubek J; Pospisil S; Lerch MLF; Petasecca M; Rosenfeld AB
Phys Med Biol; 2019 Apr; 64(8):085002. PubMed ID: 30808009
[TBL] [Abstract][Full Text] [Related]
6. An integrated system for clinical treatment verification of HDR prostate brachytherapy combining source tracking with pretreatment imaging.
Smith RL; Hanlon M; Panettieri V; Millar JL; Matheson B; Haworth A; Franich RD
Brachytherapy; 2018; 17(1):111-121. PubMed ID: 28958735
[TBL] [Abstract][Full Text] [Related]
7. Derivation of in vivo source tracking error thresholds for TRUS-based HDR prostate brachytherapy through simulation of source positioning errors.
Poder J; Carrara M; Howie A; Cutajar D; Bucci J; Rosenfeld A
Brachytherapy; 2019; 18(5):711-719. PubMed ID: 31175015
[TBL] [Abstract][Full Text] [Related]
8. Prostate CT segmentation method based on nonrigid registration in ultrasound-guided CT-based HDR prostate brachytherapy.
Yang X; Rossi P; Ogunleye T; Marcus DM; Jani AB; Mao H; Curran WJ; Liu T
Med Phys; 2014 Nov; 41(11):111915. PubMed ID: 25370648
[TBL] [Abstract][Full Text] [Related]
9. Real-time in vivo dosimetry in high dose rate prostate brachytherapy.
Mason J; Mamo A; Al-Qaisieh B; Henry AM; Bownes P
Radiother Oncol; 2016 Aug; 120(2):333-8. PubMed ID: 27236248
[TBL] [Abstract][Full Text] [Related]
10. Improved prostate delineation in prostate HDR brachytherapy with TRUS-CT deformable registration technology: A pilot study with MRI validation.
Yang X; Rossi PJ; Jani AB; Mao H; Zhou Z; Curran WJ; Liu T
J Appl Clin Med Phys; 2017 Jan; 18(1):202-210. PubMed ID: 28291925
[TBL] [Abstract][Full Text] [Related]
11. Towards real time in-vivo rectal dosimetry during trans-rectal ultrasound based high dose rate prostate brachytherapy using MOSkin dosimeters.
Poder J; Howie A; Brown R; Bucci J; Rosenfeld A; Enari K; Schreiber K; Carrara M; Bece A; Malouf D; Cutajar D
Radiother Oncol; 2020 Oct; 151():273-279. PubMed ID: 32798597
[TBL] [Abstract][Full Text] [Related]
12. In vivo rectal wall measurements during HDR prostate brachytherapy with MOSkin dosimeters integrated on a trans-rectal US probe: Comparison with planned and reconstructed doses.
Carrara M; Tenconi C; Rossi G; Borroni M; Cerrotta A; Grisotto S; Cusumano D; Pappalardi B; Cutajar D; Petasecca M; Lerch M; Gambarini G; Fallai C; Rosenfeld A; Pignoli E
Radiother Oncol; 2016 Jan; 118(1):148-53. PubMed ID: 26796593
[TBL] [Abstract][Full Text] [Related]
13. Radiation dose enhancement at tissue-tungsten interfaces in HDR brachytherapy.
Han Z; Safavi-Naeini M; Alnaghy S; Cutajar DL; Guatelli S; Petasecca M; Franklin DR; Malaroda A; Carrara M; Bucci J; Zaider M; Lerch ML; Rosenfeld AB
Phys Med Biol; 2014 Nov; 59(21):6659. PubMed ID: 25325249
[TBL] [Abstract][Full Text] [Related]
14. Validation study of ultrasound-based high-dose-rate prostate brachytherapy planning compared with CT-based planning.
Batchelar D; Gaztañaga M; Schmid M; Araujo C; Bachand F; Crook J
Brachytherapy; 2014; 13(1):75-9. PubMed ID: 24080299
[TBL] [Abstract][Full Text] [Related]
15. Electromagnetic tracking for catheter reconstruction in ultrasound-guided high-dose-rate brachytherapy of the prostate.
Bharat S; Kung C; Dehghan E; Ravi A; Venugopal N; Bonillas A; Stanton D; Kruecker J
Brachytherapy; 2014; 13(6):640-50. PubMed ID: 24929641
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of an MRI-to-ultrasound deformable image registration algorithm for prostate brachytherapy.
Shaaer A; Davidson M; Semple M; Nicolae A; Mendez LC; Chung H; Loblaw A; Tseng CL; Morton G; Ravi A
Brachytherapy; 2019; 18(1):95-102. PubMed ID: 30287271
[TBL] [Abstract][Full Text] [Related]
17. HDR prostate brachytherapy plan robustness and its effect on in-vivo source tracking error thresholds: A multi-institutional study.
Poder J; Koprivec D; Dookie Y; Howie A; Cutajar D; Damato AL; Côté N; Petasecca M; Bucci J; Rosenfeld A
Med Phys; 2022 Jun; 49(6):3529-3537. PubMed ID: 35388456
[TBL] [Abstract][Full Text] [Related]
18. HDR prostate monotherapy: dosimetric effects of implant deformation due to posture change between TRUS- and CT-imaging.
Seppenwoolde Y; Kolkman-Deurloo IK; Sipkema D; de Langen M; Praag J; Jansen P; Heijmen B
Radiother Oncol; 2008 Jan; 86(1):114-9. PubMed ID: 18054101
[TBL] [Abstract][Full Text] [Related]
19. Time-resolved clinical dose volume metrics, calculations and predictions based on source tracking measurements and uncertainties to aid treatment verification and error detection for HDR brachytherapy-a proof-of-principle study.
van Wagenberg T; Voncken R; van Beveren C; Berbee M; van Limbergen E; Verhaegen F; Paiva Fonseca G
Phys Med Biol; 2024 Jun; 69(13):. PubMed ID: 38870948
[No Abstract] [Full Text] [Related]
20. The evaluation of a 2D diode array in "magic phantom" for use in high dose rate brachytherapy pretreatment quality assurance.
Espinoza A; Petasecca M; Fuduli I; Howie A; Bucci J; Corde S; Jackson M; Lerch ML; Rosenfeld AB
Med Phys; 2015 Feb; 42(2):663-673. PubMed ID: 28102606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
